国际原子能机构儿童核医学实践国际调查
国际原子能机构(IAEA)在62个成员国的133家机构开展儿童核医学实践调查,重点覆盖低中收入国家。结果显示多数机构在DMSA、MAG3和高锝酸盐检查中给药活度超出推荐,FDG PET/CT中CT剂量长度乘积(DLP)变异大且部分偏高,提示儿童核医学实践仍需全球标准化。
要点
- 48%的机构每年儿童核医学检查量少于200例,11%超过1000例。
- DMSA、MAG3和高锝酸盐给药活度多数超出推荐,MDP依从性相对较好。
- FDG PET/CT中CT的DLP值变异大且部分偏高,需优化临床实践。
核心结论
- 全球多数地区已努力遵循EANM剂量卡或北美共识指南,但儿童核医学实践仍存在变异。
- 调查结果为儿童核医学给药活度的全球标准化提供了建议。
研究设计与样本
- IAEA发起的国际调查,共62个IAEA成员国的133家机构参与,包括非洲29家、亚洲39家、欧洲29家和拉丁美洲36家。
- 调查聚焦低中收入国家,评估儿童核医学实践现状并与NMGI调查及既定指南比较。
主要发现
- 最常见的四种单光子核医学检查为99mTc标记的MDP、DMSA、MAG3和高锝酸盐甲状腺扫描。
- 46家中心提供了FDG PET/CT数据,包括CT部分的曝光数据。
- 48%的机构每年儿童核医学检查量少于200例,11%超过1000例。
- DMSA、MAG3和高锝酸盐的给药活度在多数机构大幅超出推荐,MDP对国际标准的依从性相对较好。
- FDG PET/CT中CT使用变异大,部分DLP值偏高。
临床怎么用
- 儿童核医学给药活度应参考EANM剂量卡或北美共识指南以促进全球标准化。
- FDG PET/CT中应关注CT剂量长度乘积(DLP)的优化,降低儿童辐射暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The International Atomic Energy Agency (IAEA) decided to initiate a survey to evaluate the current status of the practice of paediatric nuclear medicine worldwide, with the focus mainly on low and middle-income countries specifically in Latin America, Eastern Europe, Africa and Asia. This investigation sought to determine if the practice in paediatric nuclear medicine in these countries differed from that indicated by the survey of the Nuclear Medicine Global Initiative (NMGI) and if nuclear medicine practitioners were following established paediatric nuclear medicine guidelines. METHODS: A total of 133 institutes took part in the survey from 62 different IAEA member states within Africa (29), Asia (39), Europe (29) and Latin America (36). The four most frequent conventional (single-photon) nuclear medicine procedures were 99mTc labelled MDP, DSMA, MAG3 and pertechnetate thyroid scans. In addition, 46 centres provided data on FDG PET/CT, including exposure data for the CT component. Nearly half of the sites (48%) perform less than 200 paediatric nuclear medicine studies per year, while 11% perform more than 1000 such studies per year. RESULTS: Administered activities largely exceeded the recommendations for most of the sites for DMSA, MAG3 and pertechnetate, while compliance with international standards was somehow better for MDP studies. For FDG PET, the results were more uniform than for conventional nuclear medicine procedures. However, the use of CT in PET/CT for paediatric nuclear medicine revealed a high variability and, in some cases, high, dose-length product (DLP) values. This observation indicates that further attention is warranted for optimizing clinical practice in FDG PET/CT. CONCLUSIONS: Overall, in most parts of the world, efforts have been undertaken to comply either with the EANM dosage card or with the North American Consensus Guidelines. However, variability in the practice of paediatric nuclear medicine still exists. The results of this survey provide valuable recommendations for a path towards global standardization of determining the amount of activity to be administered to children undergoing nuclear medicine procedures.
引用
- Poli GL, Torres L, Coca M, et al. Paediatric nuclear medicine practice: an international survey by the IAEA. Eur J Nucl Med Mol Imaging. 2019. PMID: 31813051. doi:10.1007/s00259-019-04624-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。